[{"Assets_0_Q3_USD":306202000.0,"CommonStockSharesOutstanding_0_Q3_shares":36426830.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-67063000.0,"NetIncomeLoss_1_Q3_USD":-32372000.0,"NetIncomeLoss_3_Q3_USD":-86592000.0,"StockholdersEquity_0_Q3_USD":159268000.0,"Ticker":"AERI","CIK":"1337553","name":"AERIE PHARMACEUTICALS INC","OfficialName":"Aerie Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408427417.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]